Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So I have pretty much sold off all of the shares (NVAC) and most of the warrants (NVACW) in exchange for the Rights (NVACR).
I'm using my logic, that owning future rights to a share, at 1/5th of the cost of a current share, is the best bang for the buck, especially if one's intention has always been to hold and to only sell AFTER the announcement of the target.
After all, today's shares and today's future shares will be exactly equivalent at that time (except, of course, for how much they originally cost).
Seems to me that such a move would be the equivalent to almost a 500% gain, provided the stock value doesn't decrease upon the announcement of a target (which it truly shouldn't).
Truth is that I now only have the equivalent of 2.4 times the amount of "future" stock that I had of "present" stock, as I have not yet used up all of the dry powder (ie: I am about 75% along the way, and now want to see if I can pick up some cheapies over the next 2 1/2 weeks) AND I am spending a little of that extra dry powder whenever AXIM drops below 19 cents.
Still, 2.4 times is like a 240% increase, or if being pessimistic, the stock price after acquisition could drop to a little over $4 and I still won't have realized a loss (and by selling the warrants, I further reduce the downside of the stock trading under $11.50 - the target price of the warrants).
LOL, this is kind of like riding "Dueling Dragons" at Disney, only like being on both rollercoaster rides at the same time!
The more I think on it, the more I am convinced that the Rights (NVACR) are the best way to go.
You can own 1 share of stock today @ $9.75 (Total cost for a share at desired selling time will have been = $9.75)
You can own the right to buy 1 share (@ $11.50) in the future for about $0.20 (Total cost for a share at desired selling time will have been = $11.70)
OR, you can buy the Rights to 1 future share for $2.00 (you would need to purchase 10 NVACR today at a cost of $0.20 each). (Total cost for a share at desired selling time will have been = $2.00)
If I am reading this correctly, those Rights go into effect "after a merger has commenced", which means upon the announcement of a merger target (or very soon thereafter).
Since it has always been my intention to wait until after a merger has been announced in order to sell any interests in NorthView Acquisition Corp., then owning shares or owning Rights to shares makes no difference.
In effect, the Rights give you the ability to own almost 5 times as many (whole) shares (4.875 times), which turns your investment into an automatic 487.5% gain upon the Announcement of the Acquisition Target (AOTAT) even if the current sales price for NVAC remains the same after the announcement!
If post AOTAT the price drops substantially, it would have to drop by almost 80% for you to experience a loss.
If post AOTAT the price rises, your gain could well be above 500%
Based on the above, I have a NVAC sale price target of $14.25. This would be a % increase above today's value ($9.75) of + 46%, with an effective % Rate of Return of more like over 600%.
Damn, I hope my calculations and my thinking are correct.
Godspeed.
I'm still reading and watching.
Interesting.
In a couple of weeks, I might be able to start a position in NVACR or
NVACW
Those are more in my price range.
My thoughts are that the stock (NVAC) and the rights (NVACR) will add value if the stock price rises, but it is the options/warrants (NVACW) that promise to deliver the greatest % return when the time comes (ie: announcement of acquisition - AOA).
Since the intent is to sell all 3 (NVAC, NVACR, NVACW) upon AOA, then wouldn't it make sense to sell NVAC now in exchange for NVACW?
(With the basic assumption that an AOA will occur, which is the sole purpose of the SPAC to begin with).
For that matter, upon AOA, since NVACR is 1/10th of NVAC, wouldn't it be better to sell NVAC now in exchange for NVACR, since NVAC is currently $9.74 and NVACR is much less than 1/10th of that?
NVACR is currently trading at about .17, but 1/10th of what NVAC is currently trading at is .974, so if you sell NVAC and buy NVACR, you essentially are getting more than 5x as much stock upon AOA that will be trading at (1/10th of) the price of NVAC upon AOA.
In other words, if the AOA occurred tomorrow, and NVAC remained at today's value of $9.74, then NVACR would be worth 1/10th of that, or $.974 - which is 5.7 times what it is worth today!
Doesn't that turn NVACR into an immediate, guaranteed 5 bagger upon AOA?
Going to have to sleep on this, but it seems that shifting $ out of NVAC and into NVACR and NVACW might be the prudent thing to do.....PROVIDING that the SPAC does what its whole "reason for being" is to do - Take over a acquisition target.
If my calculations are correct, then taking into consideration any "fully convertible" units purchased (ie: there is no loss because of fractions in the total number of units purchased), if you take the final share price after a target is announced and multiply that price by 1.14, then you will have the actual value of your investment (taking into consideration all of the Rights and Warrants) - as long as the final share price is above $11.50.
In other words, if NVAC goes to $15 per share, and you have a full compliment of warrants and rights from when you purchased an even number of units, then the additional value of those warrants and shares adds another .43 to the share price:
$15 x 1.14 = $17.10
So, when the time comes, those warrants and rights will add another 14% to your gross proceeds.
Now, the higher the stock price, the greater the % return from the warrants and rights:
$11.50 = 10.00% (the warrants add no value at this price)
$15.00 = 21.67%
$20 = 31.25%
$25 = 37.00%
$30 = 40.83%
$35 = 43.57%
$40 = 45.63%
"options" can return much bigger percentage gains and rewards that just purchasing the stock outright by itself.
The "rights" clearly add 10% to the final value, but it is the Warrants that result in the additional ercentage gainds at higher stock prices.
Godspeed.
Day 3 after the split:
NVACW: 504,695 shares @ $0.22
NVACR: 36,436 shares @ $0.19
NVAC: 1,575,400 shares @ $9.74
The numbers seem odd.
Should wait about a week or so to see how these numbers settle in.
Wow, yesterday - the 1st day post the unit split - was some day!
NVACW: 504,695 shares @ $0.21
NVACR: 1,590,700 shares @ $0.16
NVAC: 1,575,400 shares @ $9.70
There was a single trade of NVAC of over $4.6 million!
Total dollars worth of NVAC traded yesterday was $15 million.
And, most of the action was buys, not sales (Green trades, not red ones).
MAYBE that had something to do more with the splitting up of the units and NOT actual trades?
If that be the case, then the splitting up of the units has to certainly be complete. Everything starting this morning should all be trades.
38110
The Warrants portion of the units are now trading at FULL Warrants (each Warrant gives the holder the right to purchase an entire share at $11.50 in the future), so the number of warrants received in the split was half of the total number of units purchased.
Therefore, after Day 1 of the split, the "units" were effectively trading at $10.02, a drop of 8 cents per unit.
It appears that the following is about how the units have split up, based upon LOW BIDS:
NVAC = $9.67
NVACW = $0.22
NVACR = $0.20
....as of 1/25/2022 (1 day after split).
38110
NVAC was $9.71, NVACW closed at .22, NVACW was at .20, totaling to $10.13
The splitting of the Units has occurred, and today the new symbols are trading as follows:
NVAC $9.70 - $9.93 (0 trades so far)
NVACW $0.24 - $0.25 (141K trades)
NVACR $0.23 - $0.30 (0 trades so far)
From post #16, these were my calculations:
When you can, you might as well have fun doing it.
I played a few SPACs in 2021, and I feel I have learned a lot (from my mistakes).
Buying on "rumor" is what is occurring now. Selling on the "News" is what occurs very quickly soon after the merger/acquisition target is announced.
Also, the splitting up of a unit into its parts, to be traded separately, is a good sign that the "news" is coming soon. The Warrants and the Rights really have no value at this time, but they will once the target is secured. Splitting up the units after an announcement is just too complicated.
I think that the PR from two days ago speaks volumes. I believe a target has been found.
If you look at the chart of a typical SPAC, you will see that the best time to sell is immediately after the target of that SPAC is announced.
After that initial pop, the stock continues to slowly drop in value.
Fortunately, the stock never goes back to its pre-target announcement days, but the best profits can be found right after the acquisition news is PR'd.
Now, with the Units being split into their pieces, and 2 of the 3 pieces essentially worthless until a merger occurs, I'm thinking that is coming real soon.
I'm just going to sit tight till that something happens.
Godspeed.
38110
took a small position today. Kinda like playing 5 card stud and hanging around to get that last card.
Thinking along the lines of the dividing up of units that will occur after the close of business tonight:
After the split, there will be a price for a share, = X
The price for a Right should then be no greater than .1X (That is, 1/10th of the price of a future share)
The price of a warrant has to be X - $11.50, since why would you pay for a warrant to buy a share in the future for $11.50, if you could buy that share today for X?
Since, as of today, X - 11.50 would be a negative number, we must leave the warrants out of the equation in order for the equation to make any sense (that is, the Warrants will be worth almost nothing after the unit is split into its parts. Let's assign it a value of .01).
Therefore, using the following equation, where NVACU is the current unit price today of $10.10:
NVACU = NVAC + NVACR + NVACW
$10.10 = X + .1X +.01
Solving for X, which should be the price of a share of NorthView comes next week, we see roughly:
NVAC = $9.18
NVACW = $.01 (just to give it a minimum value)
NVACR = $.91
So, I am going to say that, since NVACR only has value when a business relationship is consummated sometime in the future, then comes end of next week, the split up units will be trading more likjely as follows:
NVAC.......... = $9.80 to $9.95
NVACW....... = $0.01 to $0.05
NVACR....... = $0.30 to $0.40
LOL....let's see how far off I am.
35440
Good luck with your investments as well. Hope the NVACU works out for you.
I'm still thinking there is a focus on EmpoweredDiagnostics.
My big idea is for Empowered Diagnostics to eventually merge with AXIM and Empowered management to eventually run the combined company.
But that is just me.
I'll keep them in mind, but I did go all in with NVACU these last 2 weeks, so capital is tied up for a bit.
I see NorthView as a quick in and out, with the possibility to double or triple the investment in a very short time.
I have no intentions of holding a share, a warrant, or a right more than 3 or 4 days after they PR a target.
Really, with the amount of shares I picked up, I should be able to get out in less than a day.
Good luck with all your investments.
Yes. August 2021.
Northview Acquisition will only be a curiosity for me. I don't have any plans or money to invest in Northview.
But will continue to add cheap AXIM shares at these prices.
Another penny stock Biotech/Biopharma I like is ACRX with FDA approved DSUVIA (DSUVIO in Europe). Lots of great news in 2021. Also a $30 million contract with department of defense.
Price of ACRX is very beat down. 2022 should be the year the tide finally turns. Acquisition of Lowell Therapeutics in late 2021.
My apologies, those years (2020 and 2021) were so clear in my previous post, I don't know how that got past me.
Then again, August 2022? Are you looking into a crystal ball, because that's like 7 months in the future........
Sapphire Biotech was acquired in 2020.
Advanced Tear Diagnostics was acquired 16 months later in August 2021.
I would have to look at my StockTwits posts, but I think I found the Northview Acquisition Corporation information in July 2021.
Then in August 2022, AXIM announced their Acquisition of the Dry Eye Disease tests from Advanced Tear Diagnostics LLC.
Catalina Valencia (CEO of Sapphire Biotech) was a past Chief Legal Officer of Advanced Tear Diagnostics LLC.
Yes, there is. Peter's involvement with NorthView is completely transparent.
A thought occurred to me yesterday:
Did you say that you were watching NorthView from about April 2021? I found this in the media:
I took the bait and will follow this board for awhile.
Personally I don't own any shares yet, but I am curiously watching Northview Acquisition Corporation.
It is very Curious that Peter O'Rourke is Chairman of this Board and also on the board of directors for AXIM.
At the very least there has to be openness between Peter O'Rourke and the AXIM bod as to what his intentions are.
At close of business on January 21, 2022, the Units of NVACU were split as follows:
Before COB on 1/21/2022:
NVACU = the "Unit", which consisted of 1 share, 1/2 warrant, and 1/10th Right
After COB on 1/21/2022:
NVAC = Common Share
NVACW = A Warrant, 1 Warrant issued for every 2 units owned, no warrants for a single (or odd numbered) unit, warrants are for the future purchase of a share of NVAC @ $11.50, regardless of the market price.
NVACR = Rights, 1/10th of a Right issued for every unit. Apparently, there will be shares issued in 10ths, as I have not seen a restriction as to ownership of fractions of units in lots less than 10 units. The Right is for 1/10th of a common share upon the successful consummation ("joining") of a business relationship.
By buying units in lots of 10, an investor will not lose in the case of a half warrant (since the units purchased are in even numbers), AND the investor will NOT wind up with any fractional shares upon business consummation.
With yesterday's Press Release, stating that comes the close of business this Friday (1/21/2022), the NorthView "units" currently being sold (NVACU) will be split into three pieces and thereafter trade as three separate entities (NVAC for the shares portion, NVACR for the Rights portion, and NVACW for the Warrants portion), I shot off my last round of purchases, achieving a share level slightly more than I had originally expected.
Now it is just a matter of waiting for "the News" (ie: the "rumors" portion, for me at least, has come to a close).
Interestingly, the average share volume is currently being reported at 361,957 shares per day, with today's volume so far just at 6,479 shares (of which, a certain blind squirrel had a hand in 85% of them).
My thoughts are two-fold:
1. Splitting up the units into three separate pieces, each of which is to be traded separately, must be a sign that the SPAC is quickly moving forward (ie: a target has been found). CLEARLY, the warrants to buy NVAC at $11,50 have absolutely no value today, since even in tact entire units are trading way under that value ($10.10 per unit). The same is true of the Rights, which only kick in when NorthView consummates a deal of some sort. Currently, those Rights are worthless, especially when one considers that if a merger doesn't occur within 2 years, all of the $ collected by the SPAC must be returned, and the Rights will have absolutely no value. So my thoughts are, the only logic in splitting the units now into 3 separately tradeable entities, is that there is an event coming, in the very near future, that will make each separate entity worth trading (and THAT is most likely an announcement of an acquisition target).
2. Most of the time, when you split things up, the value of the pieces is greater than the value of the whole (think about how a car's parts are worth more than the car itself, or how after a stock split, the new sum of the parts are worth more than the original whole). Along those lines, anyone who just wanted to own Shares would have had (up unto close of business tomorrow) to buy entire units, and essentially "pay something extra" for the two other pieces (Rights and Warrants) which they didn't want. NOW, however, starting next week, anyone who wishes only to hold shares can (theoretically) sell off the Rights and/or Warrants that they are not interested in, and anyone who just wants Shares and nothing else now has the ability to acquire exactly what they want. Here to, in this situation, the sum total of the parts should ultimately turn out to be greater than the unit as a whole. In other words, the $10.10 spent on a unit today will have a (slightly) greater value when the parts are summed up next week (such as $10.15?, etc.).
If nothing else, the Press Releases shows progress moving forward, which is the whole purpose of the SPAC....to move forward and actually "buy" something.
35330
NorthView Acquisition Corp. announced today that, on January 21, 2022, the Company’s units will no longer trade as "a unit", which originally consisted of:
NVACU (the "U" meaning "Unit"):
1 share,
1/10th of a RIGHT to a share to be issued upon a merger,
1/2 of a WARRANT TO PURCHASE the stock at $11.50 (regardless of market price),
will after this Friday, now be split into and trade under the separate symbols:
Common Stock (NVAC),
Rights (NVACR)
Redeemable Warrants (NVACW),
https://www.globenewswire.com/news-release/2022/01/19/2369708/0/en/NorthView-Acquisition-Corp-Announces-Upcoming-Automatic-Unit-Separation.html
NorthView Acquisition Corp. is a blank check company organized for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus its initial search on target businesses in the healthcare sector with an enterprise value of approximately $500 million to $2 billion.
Yet another good day.
Just waiting for some fresh powder to become available next week.
Godspeed to all on this venture.
29760
Liking this new board!
It's like my own, online, AXIM/NVACU Diary, where I can say whatever I want, and if I am right, I can refer people back to this site some day in the future.
If I am wrong, well, no one will ever find this place.
LOF'ingL!
26249
The goal I see here, as it relates to a SPAC, is to buy at a certain price and be prepared for the SPAC to remain there, at that very same price, until a target is announced.
In a strong sense, buying a SPAC is like putting your $ in a bank. After all, the SPAC has minimal expenses, and the funds "deposited" into a SPAC are held with the specific purpose of buying something.
Trump's SPAC, DWAC (Digital World Acquisition Corp.) is moving up, but that is because of the growing expectation that DWAC is going to scoop up all the "fake news" networks when Truth Social comes out (2/21/2022) and the stock values of all of those other media stations start to tank.
In essence, DWAC has already named its target(s) even before it actually and publicly announces what its target will be.
Keep a wary eye on this one.
https://www.globenewswire.com/news-release/2021/12/23/2357419/0/en/NorthView-Acquisition-Corp-Announces-Closing-of-189-750-000-Initial-Public-Offering-Including-Full-Exercise-of-Underwriter-Over-Allotment-Option.html
As Peter O'Rouke is both on the Board at AXIM Biotechnologies, and a member of NorthView Sponsor I, LLC (which owns 4,743,750 shares of NVACU), I think this is worth watching.
Is NorthView Acquisition Corp.'s initial purpose to bring AXIM's manufacturing partner (Empowered Diagnostics) public?
Once the Special Purpose Acquisition Corp. accomplishes that first phase, where would it go from there?
Acquire other manufacturing companies?
Merge with AXIM Biotechnologies?
Then what?
My gut tells me that AXIM will get its long-awaited approval (EUA) for Immunopass sometime in early February, 2022. (02/02/2022, 02/20/2022, 02/22/2022?)
I don't think it is a coincidence that Mr. O'Rouke has connections to both AXIM and NVACU, and that NVACU had its IPO just a few weeks ago (12/23/21).
Peter O'Rouke looks like a brilliant man with the ability to see the future.
Can't hurt to ride along on those coat tails.
I also like the offer: 1 unit = 1 share of NVACU, plus 1/2 warrant to buy NVACU at $11.50, plus 1/10th of a share of NVACU once an acquisition is consummated.
I've been accumulating @ $10.10 since 1/10 in lots of 10 shares.
Let's see where this one goes.
19253
Followers
|
3
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
122
|
Created
|
01/17/22
|
Type
|
Free
|
Moderators |
NorthView Acquisition Corp. is a blank check company organized for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus its initial search on target businesses in the healthcare sector with an enterprise value of approximately $500 million to $2 billion. On January 19, 2022, NorthView announced that its unit (NVACU), which consisted of 1 share, 1/2 warrant (to buy shares at $11.50), and 1/10th of a right (to a share after a merger has commenced) would be split into 3 different trading symbols as such: NVAC = common shares, NVACW = Warrants, NVACR = Rights. Accordingly, any fractions would be rounded downward, so any purchases of the "unit" (NVACU) prior to this date, should best be done in groups of 2 units, or 10 units if you are not interested in potentially having fractions of a share once a relationship with another company is consummated.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |